You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
McKesson
Boehringer Ingelheim
Baxter
Merck

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

CHLOROMYCETIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Chloromycetin patents expire, and what generic alternatives are available?

Chloromycetin is a drug marketed by Parke Davis and Parkedale and is included in seven NDAs.

The generic ingredient in CHLOROMYCETIN is chloramphenicol; hydrocortisone acetate. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol; hydrocortisone acetate profile page.

Summary for CHLOROMYCETIN
Drug patent expirations by year for CHLOROMYCETIN

US Patents and Regulatory Information for CHLOROMYCETIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis CHLOROMYCETIN chloramphenicol CREAM;TOPICAL 050183-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parkedale CHLOROMYCETIN HYDROCORTISONE chloramphenicol; hydrocortisone acetate FOR SUSPENSION;OPHTHALMIC 050202-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parkedale CHLOROMYCETIN chloramphenicol sodium succinate INJECTABLE;INJECTION 050155-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Parkedale CHLOROMYCETIN chloramphenicol FOR SOLUTION;OPHTHALMIC 050143-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.